FDA Adverse Event Injury Summary report: N

LEICA ASP300S

MDR report key: 7278413 · Received February 16, 2018

Report

Report Number
1423337-2018-00002
Event Type
Injury
Date Received
February 16, 2018
Date of Event
January 19, 2018
Report Date
January 19, 2018
Manufacturer
LEICA BIOSYSTEMS NUSSLOCH GMBH
Product Code
IEO
Adverse Event
Yes
Report Source
Distributor report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Description of Event or Problem · 1

ON (B)(6) 2018, LEICA BIOSYSTEMS WAS NOTIFIED THAT THE CUSTOMER EXPERIENCED SUBOPTIMAL TISSUE PROCESSING ON THEIR ASP300S TISSUE PROCESSOR. AS A RESULT, TWO ENDOMETRIAL BIOPSIES WERE UNDIAGNOSABLE. A RE-BIOPSY WAS RECOMMENDED; HOWEVER AS OF (B)(6) 2018, NO INFORMATION HAS BEEN PROVIDED TO LEICA BIOSYSTEMS TO CONFIRM WHETHER THE RE-BIOPSY HAS BEEN PERFORMED. NO RE-BIOPSY SAMPLE HAS BEEN RECEIVED BY THE LAB. A FOLLOW UP REPORT WILL BE SUBMITTED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

FOLLOWING THE LEICA MANUFACTURER'S INVESTIGATION IT WAS DETERMINED THE INCIDENT WAS RELATED TO A PRESSURE FAILURE OF THE INSTRUMENT. TO DATE, A RE-BIOPSY HAS NOT BEEN PERFORMED. SEE MANUFACTURER'S REPORT NUMBER 8010478-2018-00001 FOLLOW UP #01 FOR ADDITIONAL INFORMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
119332 LEICA ASP300S ASP300S IEO LEICA BIOSYSTEMS NUSSLOCH GMBH 14047643515

Patients

Seq Age Sex Outcome Treatment
1 Other